28153522|t|CDK5 inhibitors prevent astroglial apoptosis and reactive astrogliosis by regulating PKA and DRP1 phosphorylations in the rat hippocampus
28153522|a|Status epilepticus (SE) results in the unique pattern of dynamin-related protein 1 (DRP1)-mediated mitochondrial dynamics, which is associated with astroglial apoptosis and reactive astrogliosis in the regional - specific pattern representing the differential astroglial properties. However, less defined are the epiphenomena / upstream effecters for DRP1 phosphorylation in this process. Since cyclin-dependent kinase 5 (CDK5) is involved in reactive astrogliosis, CDK5 is one of the possible upstream regulators for DRP1 phosphorylation. In the present study, both olomoucine and roscovitine (CDK5 inhibitors) effectively ameliorated SE - induced astroglial apoptosis in the dentate gyrus without changed seizure susceptibility. In addition, they inhibited reactive astrogliosis in the CA1 region independent of neuronal death induced by SE. These effects of CDK5 inhibitors were relevant to abrogation of altered DRP1 phosphorylation ratio and mitochondrial length induced by SE. CDK5 inhibitors also negatively regulated protein kinase A (PKA) activity in astrocytes. Therefore, our findings suggest that CDK5 inhibitors may mitigate astroglial apoptosis and reactive astrogliosis accompanied by modulations of DRP1 -mediated mitochondrial dynamics.
28153522	0	4	CDK5	T116,T126	C1565308
28153522	5	15	inhibitors	T121	C0014432
28153522	16	23	prevent	T169	C1292733
28153522	24	34	astroglial	T025	C0004112
28153522	35	44	apoptosis	T043	C0162638
28153522	49	57	reactive	T080	C0205332
28153522	58	70	astrogliosis	T046	C3887640
28153522	74	84	regulating	T044	C1148560
28153522	85	88	PKA	T116,T126	C0010531
28153522	93	97	DRP1	T116,T126	C1957127
28153522	98	114	phosphorylations	T044	C0031715
28153522	122	125	rat	T015	C0034721
28153522	126	137	hippocampus	T023	C0019564
28153522	138	156	Status epilepticus	T047	C0038220
28153522	158	160	SE	T047	C0038220
28153522	162	169	results	T169	C1274040
28153522	177	183	unique	T080	C1710548
28153522	184	191	pattern	T082	C0449774
28153522	195	220	dynamin-related protein 1	T116,T126	C1957127
28153522	222	226	DRP1	T116,T126	C1957127
28153522	237	259	mitochondrial dynamics	T043	C3494415
28153522	270	285	associated with	T080	C0332281
28153522	286	296	astroglial	T025	C0004112
28153522	297	306	apoptosis	T043	C0162638
28153522	311	332	reactive astrogliosis	T046	C3887640
28153522	340	348	regional	T082	C0205147
28153522	351	359	specific	T080	C0205369
28153522	360	367	pattern	T082	C0449774
28153522	385	397	differential	T080	C1705242
28153522	398	408	astroglial	T025	C0004112
28153522	409	419	properties	T080	C0871161
28153522	451	463	epiphenomena	UnknownType	C0878643
28153522	466	484	upstream effecters	T123	C0574031
28153522	489	493	DRP1	T116,T126	C1957127
28153522	494	509	phosphorylation	T044	C0031715
28153522	518	525	process	T067	C1522240
28153522	533	558	cyclin-dependent kinase 5	T116,T126	C1565308
28153522	560	564	CDK5	T116,T126	C1565308
28153522	569	577	involved	T169	C1314939
28153522	581	602	reactive astrogliosis	T046	C3887640
28153522	604	608	CDK5	T116,T126	C1565308
28153522	623	631	possible	T080	C1705910
28153522	632	651	upstream regulators	T123	C0574031
28153522	656	660	DRP1	T116,T126	C1957127
28153522	661	676	phosphorylation	T044	C0031715
28153522	693	698	study	T062	C2603343
28153522	705	715	olomoucine	T109,T121	C0289993
28153522	720	731	roscovitine	T109,T121	C0536217
28153522	733	737	CDK5	T116,T126	C1565308
28153522	738	748	inhibitors	T121	C0014432
28153522	750	761	effectively	T080	C1280519
28153522	762	773	ameliorated	T169	C0332303
28153522	774	776	SE	T047	C0038220
28153522	779	786	induced	T169	C0205263
28153522	787	797	astroglial	T025	C0004112
28153522	798	807	apoptosis	T043	C0162638
28153522	815	828	dentate gyrus	T023	C0152314
28153522	829	836	without	T080	C0332288
28153522	837	844	changed	T081	C0443172
28153522	845	852	seizure	T184	C0036572
28153522	853	867	susceptibility	T081	C1547045
28153522	887	896	inhibited	T080	C0311403
28153522	897	918	reactive astrogliosis	T046	C3887640
28153522	926	936	CA1 region	T029	C0694598
28153522	937	951	independent of	T169	C0332291
28153522	952	966	neuronal death	T043	C2754100
28153522	967	974	induced	T169	C0205263
28153522	978	980	SE	T047	C0038220
28153522	988	998	effects of	T080	C1704420
28153522	999	1003	CDK5	T116,T126	C1565308
28153522	1004	1014	inhibitors	T121	C0014432
28153522	1020	1028	relevant	T080	C2347946
28153522	1054	1058	DRP1	T116,T126	C1957127
28153522	1059	1074	phosphorylation	T044	C0031715
28153522	1075	1080	ratio	T081	C0456603
28153522	1085	1098	mitochondrial	T026	C0026237
28153522	1099	1105	length	T081	C1444754
28153522	1106	1113	induced	T169	C0205263
28153522	1117	1119	SE	T047	C0038220
28153522	1121	1125	CDK5	T116,T126	C1565308
28153522	1126	1136	inhibitors	T121	C0014432
28153522	1142	1152	negatively	T033	C1513916
28153522	1153	1179	regulated protein kinase A	T116,T126	C0010531
28153522	1181	1184	PKA	T116,T126	C0010531
28153522	1186	1194	activity	T044	C0243102
28153522	1198	1208	astrocytes	T025	C0004112
28153522	1225	1233	findings	T033	C0243095
28153522	1234	1241	suggest	T078	C1705535
28153522	1247	1251	CDK5	T116,T126	C1565308
28153522	1252	1262	inhibitors	T121	C0014432
28153522	1267	1275	mitigate	T067	C1553901
28153522	1276	1286	astroglial	T025	C0004112
28153522	1287	1296	apoptosis	T043	C0162638
28153522	1301	1309	reactive	T080	C0205332
28153522	1310	1322	astrogliosis	T046	C3887640
28153522	1338	1349	modulations	UnknownType	C0678672
28153522	1353	1357	DRP1	T116,T126	C1957127
28153522	1368	1390	mitochondrial dynamics	T043	C3494415